Background illustration for clinical trials search

Sanofi Clinical Trials

Find clinical trials for Sanofi. Search for Sanofi clinical trials in different cities and states across the United States.

Filter

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for
Solid Tumor
Location: Providence RI, New York NY, Hackensack NJ, Newark DE,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT05584670

Phase 1, Phase 2, Recruiting

A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)

for
Niemann-Pick Diseases, Acid Sphingomyelinase Deficiency
Location: Philadelphia PA, Columbus OH, Cincinnati OH, Chicago IL,
Sponsor: Sanofi

Sex: All

Age: 0 - 2

Code: NCT06192576

Recruiting

The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Durham NC, Columbus OH, Indianapolis IN, Lawrence KS,
Sponsor: Sanofi

Sex: All

Age: 40+

Code: NCT07612878

Recruiting

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

for
Atopic Dermatitis
Location: Portsmouth NH, Warwick RI, Falls Church VA,
Sponsor: Sanofi

Sex: All

Age: 12+

Code: NCT07290803

Recruiting

A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease

for
Immunoglobulin G4 Related Disease
Location: Boston MA, Sherbrooke, New York NY, Montreal,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07190196

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1

for
Myotonic Dystrophy
Location: New York NY, Montreal, Philadelphia PA, Richmond VA,
Sponsor: Sanofi

Sex: All

Age: 10 - 55

Code: NCT06844214

Phase 1, Phase 2, Recruiting

Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)

for
Polyneuropathy, Inflammatory Demyelinating, Chronic
Location: Swiftwater PA
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT06968975

Recruiting
New

An Open-label DDI Study to Investigate the Effect of Rilzabrutinib on P-gp, BCRP, OATP1B1 and OATP1B3 Inhibition

for
Healthy Volunteer
Location: Quebec
Sponsor: Sanofi

Sex: All

Age: 18 - 55

Code: NCT07855250

Phase 1, Recruiting
New

A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)

for
Chronic Obstructive Pulmonary Disease
Location: Boynton Beach FL, Newport Beach CA
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07793409

Phase 3, Recruiting
New

Study of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and People at Increased Risk of Severe COVID-19

for
COVID-19
Location: Philadelphia PA, Rockville MD, Richmond VA, Doral FL,
Sponsor: Sanofi

Sex: All

Age: 12+

Code: NCT07861542

Phase 4, Recruiting

A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction

for
Lung Transplant Rejection
Location: The Bronx NY, New York NY, Philadelphia PA,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT06082037

Phase 3, Recruiting

Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

for
Plasma Cell Myeloma Refractory
Location: Buffalo NY, Columbus OH, Atlanta GA, Ann Arbor MI
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT04643002

Phase 1, Phase 2, Recruiting

Avalglucosidase Alfa Pregnancy Study

for
Pompe Disease, Pregnancy
Location: Bridgewater NJ
Sponsor: Sanofi

Sex: Female

Age: 0+

Code: NCT05734521

Recruiting

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

for
Focal Segmental Glomerulosclerosis,
Location: Quebec, The Bronx NY, New York NY, Montreal,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT06500702

Phase 2, Recruiting

A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

for
Plasma Cell Myeloma Refractory
Location: Sherbrooke, Hackensack NJ, Montreal, Philadelphia PA,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT06630806

Phase 1, Recruiting

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

for
Pruritus
Location: New York NY, Verdun, Baltimore MD, Washington D.C. DC,
Sponsor: Sanofi

Sex: All

Age: 18 - 70+

Code: NCT05263206

Phase 3, Recruiting

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Boston MA, New Haven CT, Quebec, New York NY,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT06290141

Phase 3, Recruiting

Registry for Stage 2 Type 1 Diabetes

for
Type 1 Diabetes
Location: New Haven CT, Manhasset NY, Staten Island NY,
Sponsor: Sanofi

Sex: All

Age: 0+

Code: NCT06481904

Recruiting

A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

for
Juvenile Idiopathic Arthritis
Location: Calgary
Sponsor: Sanofi

Sex: All

Age: 1 - 17

Code: NCT02991469

Phase 2, Recruiting

A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

for
Dementia, Alzheimer's Type, Alzheimer's Disease
Location: Newton MA, Springfield NJ, Plymouth Meeting PA,
Sponsor: Sanofi

Sex: All

Age: 55 - 70+

Code: NCT07688213

Phase 2, Recruiting